Curtis Pickert - Mar 1, 2023 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role: EVP, Chief Operating Officer
Signature: /s/ Mary Ann E. Moore, Attorney-in-Fact
Stock symbol: MD
Transactions as of: Mar 1, 2023
Transactions value $: -$36,202
Form type: 4
Date filed: 3/3/2023, 04:00 PM
Previous filing: Feb 22, 2023
Next filing: May 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Award	$0	+55.7K	+190.33%	$0.00	84.9K	Mar 1, 2023	Direct	F1
transaction	MD	Common Stock	Tax liability	-$36.2K	-2.3K	-2.71%	$15.74	82.6K	Mar 1, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2024, twenty-five percent (25%) of the restricted shares will vest on March 1, 2025 and fifty percent (50%) of the restricted shares will vest on March 1, 2026, subject to the terms of the Plan.
F2	Represents 2,300 restricted shares withheld for payment of taxes upon vesting of shares.

Content

Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2024, twenty-five percent (25%) of the restricted shares will vest on March 1, 2025 and fifty percent (50%) of the restricted shares will vest on March 1, 2026, subject to the terms of the Plan.

Represents 2,300 restricted shares withheld for payment of taxes upon vesting of shares.